JOY MILLET: Open Payments
NPI 1265020739 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,754 in 150 payments from 50 companies in 2025. Trend: 2023 $3,772 · 2024 $3,381 · 2025 $3,754
Food & beverage: $3,681Education: $80
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 10 | $264 |
| AstraZeneca Pharmaceuticals LP | 9 | $220 |
| Eisai Inc. | 9 | $201 |
| Merck Sharp & Dohme LLC | 7 | $196 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $184 |
| Janssen Biotech, Inc. | 8 | $174 |
| Daiichi Sankyo Inc. | 7 | $161 |
| PUMA BIOTECHNOLOGY, INC. | 4 | $152 |
| Novartis Pharmaceuticals Corporation | 6 | $143 |
| Gilead Sciences, Inc. | 4 | $112 |
Products named: Lenvima, KEYTRUDA, Enhertu, NERLYNX, JAKAFI, Trodelvy, CARVYKTI, XT CDX.
Industry payments across FL — which companies pay providers there.
